Lower Urinary Tract Symptoms (LUTS) after Aquablation for the treatment of Benign Prostatic Hyperplasia (BPH): Evaluation of symptoms category (filling versus voiding phase) prevalence rates

被引：0

作者：

De Cillis, S. T. ^{[1
]}

De Luca, S. ^{[1
]}

Amparore, D. ^{[1
]}

Checcucci, E. ^{[2
]}

Piramide, F. ^{[1
]}

Piana, A. ^{[1
]}

Volpi, G. ^{[1
]}

Sica, M. ^{[1
]}

Verri, P. ^{[1
]}

Meziere, J. ^{[1
]}

Zamengo, D. ^{[1
]}

Quara, A. ^{[1
]}

Cisero, E. ^{[1
]}

Busacca, G. ^{[1
]}

Colombo, M. ^{[1
]}

Cidda, D. ^{[1
]}

Gatti, C. ^{[1
]}

Sterrantino, A. ^{[1
]}

Ortenzi, M. ^{[1
]}

Manfredi, M. ^{[1
]}

Fiori, C. ^{[1
]}

Porpiglia, F. ^{[1
]}

机构：

[1] AOU San Luigi Gonzaga, Dept Urol, Turin, Italy

[2] Candiolo Canc Inst FPO IRCCS, Dept Surg, Candiolo, Italy

来源：

EUROPEAN UROLOGY | 2023年 / 83卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

A0019

引用

页码：S27 / S28

页数：2

共 50 条

[21] Switch from phytotherapy to tamsulosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
Gross, AJ
Busse, M
Leonard, J
Schumacher, H
PROSTATE CANCER AND PROSTATIC DISEASES, 2005, 8 (03) : 210 - 214
[22] Integrating the patient risk profile in the management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
Artibani, W
EUROPEAN UROLOGY SUPPLEMENTS, 2004, 3 (04) : 1 - 6
[23] Switch from phytotherapy to tamsulosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
A J Gross
M Busse
J Leonard
H Schumacher
Prostate Cancer and Prostatic Diseases, 2005, 8 : 210 - 214
[24] Re: Burden of Male Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia (BPH)-Focus on the UK
Kaplan, Steven A.
JOURNAL OF UROLOGY, 2016, 195 (02): : 425 - +
[25] A practical primary care approach to lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH-LUTS)
Rosenberg, Matt T.
Witt, Erik S.
Miner, Martin
Barkin, Jack
CANADIAN JOURNAL OF UROLOGY, 2014, 21 : 12 - 24
[26] α1-adenoceptor antagonists for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH):: State of the art
Djavan, B
EUROPEAN UROLOGY SUPPLEMENTS, 2004, 3 (04) : 23 - 30
[27] Integrating patient risk profiles in the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) in clinical practice
Speakman, MJ
EUROPEAN UROLOGY SUPPLEMENTS, 2004, 3 (04) : 18 - 22
[28] Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment
Roehrborn, Claus G.
Egan, Kathryn B.
Miner, Martin M.
Ni, Xiao
Wong, David G.
Rosen, Raymond C.
BJU INTERNATIONAL, 2016, 118 (01) : 153 - 160
[29] The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms Prevalence and Incident Rates
Egan, Kathryn Brigham
UROLOGIC CLINICS OF NORTH AMERICA, 2016, 43 (03) : 289 - +
[30] Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms
Sarma, Aruna V.
Wei, John T.
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (03): : 248 - 257

← 1 2 3 4 5 →